News

Bayer expands into molecular imaging with 2 acquisitions

The company has reached a deal to purchase two investigational imaging agents from Attralus Inc., a Naples, Florida-based biopharmaceutical firm.

AI roundup: FDA reassures innovators, Claude challenges ChatGPT, health system goes DIY with AI, more

The FDA wants to encourage designers of goods in two health-tech categories to worry more about supplying innovative products than about pleasing the FDA.

Senate Report: UnitedHealth was aggressive in seeking higher Medicare Advantage payments

The Wall Street Journal obtained a copy of a report from the Senate Judiciary Committee, which reviewed over 50,000 documents sent by UnitedHealth related to its Medicare Advantage patients. The outlet published the findings of the inquiry.

scale money prices shopping transparency reimbursement dollar coins

Cash prices frequently undercut insurance rates at Texas hospitals, study finds

Research from healthcare data analytics firm Trilliant Health found that negotiated rates carry a higher price tag for common services, calling into question the value of transparency regulations.

MRI technique reduces low-value surgeries for patients with colorectal cancer

Though effective, surgery for colorectal peritoneal metastases is accompanied by a high risk of major morbidity, making the decision to undergo the procedure complex for many patients.

Outsourcing may actually be adding to in-house radiologists' workloads

As organizations turn to external services for help, it is becoming increasingly important for leaders to evaluate how this practice impacts patient care and the bottom line.

Lawsuit alleges crew failed to act after man suffered stroke on flight

According to a new wrongful death lawsuit, members of the flight crew failed to pick up on a man's stroke symptoms, resulting in significant care delays. His family is now suing for damages in excess of $50,000.

Sunil Rao, MD, MSCAI, director, interventional cardiology, cardiac catheterization laboratory, NYU Langone Heart, professor, Department of Medicine, the Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine, explains the prevalence, trends and predictors of same day discharge after percutaneous coronary intervention (PCI) data for non-ST-elevation acute coronary syndrome (NSTE-ACS) in clinical practice from the NCDR-CathPCI Registry.

Same-day discharge after PCI for NSTE-ACS is on the rise

Sunil Rao, MD, told Cardiovascular Business that same-day discharge is still relatively rare for these patients, but it appears to be growing more common over time. The COVID-19 pandemic appears to have played a key role in the development of this trend.

Denise Busman from MedAxoim explains importance of the business management model in cardiology departments. She presented in a business of cardiology session at ACC 2024. #Medaxoim #ACC #ACC2024

Why your cardiology department's leadership structure matters

The way a cardiology department's management is organized can have a direct impact on physician satisfaction and patient care. "Without good governance and leadership, nothing else matters," one expert said.

Changes in AI-based risk scores identify women at greatest risk of developing breast cancer

The more an individual’s score changes, the greater the odds are of them being diagnosed with cancer in the near future, new research presented at SIIM 2024 suggests.

MRI safety concerns prompt FDA to issue recall for series of ventilators

The Class I recall affects the ZOLL 731 Series Ventilator family, including the AEV, EMV+, and Eagle II models.

lantheus acquires rights from life molecular imaging

Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M

One of the largest radiopharma companies in the world is acquiring global rights to a pair of novel therapeutic and diagnostic drugs used to target a peptide receptor overexpressed in prostate and breast cancers.

Around the web

Radiology Business

Bayer expands into molecular imaging with 2 acquisitions

The company has reached a deal to purchase two investigational imaging agents from Attralus Inc., a Naples, Florida-based biopharmaceutical firm.